The Cardiac Exchange

Penditure Exclusion System: Left Atrial Appendage ManagementHost: Pieter KappeteinGuests: Dr. Robert Hawkins – Frankel Cardiovascular Center, University of Michigan, Dr. Gianluca Torregrossa – Lankenau Medical Center, Philadelphia Segment 2: Robotic Closure, Appendage management for all AFib patients

Penditure Exclusion System: Left Atrial Appendage ManagementHost: Pieter KappeteinGuests: Dr. Robert Hawkins – Frankel Cardiovascular Center, University of Michigan, Dr. Gianluca Torregrossa – Lankenau Medical Center, Philadelphia Segment 1: Candidates, Circumstances, Clip Placement

Listen as Professor Pieter Kappetein discusses left atrial appendage management with Dr. Kelley Hutcheson of Baylor, Scott and White, Dr. Jeffrey Miller of Emory University School of Medicine , Dr. Basel Ramlawi of Lankenau Heart Institute and Dr. Gregory Rushing of University Hospitals.

Listen as Professor Pieter Kappetein discusses left atrial appendage management with Dr. Kelley Hutcheson of Baylor, Scott and White, Dr. Jeffrey Miller of Emory University School of Medicine , Dr. Basel Ramlawi of Lankenau Heart Institute and Dr. Gregory Rushing of University Hospitals.

Listen as Professor Pieter Kappetein discusses left atrial appendage management with Dr. Kelley Hutcheson of Baylor, Scott and White, Dr. Jeffrey Miller of Emory University School of Medicine , Dr. Basel Ramlawi of Lankenau Heart Institute and Dr. Gregory Rushing of University Hospitals.

Listen as Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, speaks with Dr. Juan Crestanello of Mayo Clinic in Rochester, MN, Dr. Mark Cunningham of Brigham and Women's Hospital in Boston, MA, and Dr. Katherine Harrington of Baylor, Scott, and White in Plano, TX, about anticoagulation after bioprosthetic aortic valve replacement.

Listen as Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, speaks with Dr. Juan Crestanello of Mayo Clinic in Rochester, MN, Dr. Mark Cunningham of Brigham and Women's Hospital in Boston, MA, and Dr. Katherine Harrington of Baylor, Scott, and White in Plano, TX, about anticoagulation after bioprosthetic aortic valve replacement.

Listen as Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, speaks with Dr. Juan Crestanello of Mayo Clinic in Rochester, MN, Dr. Mark Cunningham of Brigham and Women's Hospital in Boston, MA, and Dr. Katherine Harrington of Baylor, Scott, and White in Plano, TX, about anticoagulation after bioprosthetic aortic valve replacement.

Listen as Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, speaks with Dr. Juan Crestanello of Mayo Clinic in Rochester, MN, Dr. Mark Cunningham of Brigham and Women's Hospital in Boston, MA, and Dr. Katherine Harrington of Baylor, Scott, and White in Plano, TX, about anticoagulation after bioprosthetic aortic valve replacement.

Cardiac surgeons Dr. Michael Reardon from Houston Methodist and Dr. Bradley Leshnower from Emory University with interventional cardiologist Dr. Sachin Goel from Houston Methodist discuss SAVR versus TAVR. Topics include: which patients benefit from SAVR procedures, considerations for optimizing SAVR via root enlargement, and lifetime patient management as it relates to SAVR versus